CGBIO (CEO Hyun Seung Yu), a leading bio-regenerative medicine company, announced on the 14th that it held a meeting with Indonesia’s Minister of Health to discuss strategies for local medical device production, technological cooperation, and talent development. The meeting was attended by Hyun Seung Yu, CEO of CGBIO, Budi Gunadi Sadikin, Indonesia’s Minister of Health, and key representatives from both sides.
During the meeting, CGBIO presented specific plans for establishing a medical device manufacturing facility in Indonesia and expanding local production using domestic resources. These efforts aim not only to comply with Indonesia’s TKDN (Tingkat Komponen Dalam Negeri, Local Content Requirement) policy but also to enhance the competitiveness of CGBIO’s medical devices in the local market while increasing export opportunities. Additionally, CGBIO is strengthening its partnership with Universitas Indonesia (UI), Indonesia’s top national university, through joint research initiatives to develop medical devices that suitable for local healthcare needs.
The discussion also included strategies to support the development of Indonesia’s medical industry by educating local talent. To achieve this, CGBIO plans to establish a Cadaver Education and Training Center in Bali, enabling medical professionals to practice surgical techniques in a realistic training environment. Furthermore, the company is working closely with the Ministry of Health to create training programs in South Korea, allowing Indonesian healthcare professionals to gain direct exposure to advanced medical systems.
This collaboration goes beyond simply supplying medical devices. It aims to improve the sustainability of Indonesia’s medical device manufacturing sector while promoting research collaboration and technology transfer. These initiatives align with CGBIO’s broader vision of establishing Indonesia as a major medical device hub in Asia.
Hyun Seung Yu, CEO of CGBIO, said, “Local production of medical devices is not just about building factories. It is about ensuring that Indonesian citizens have better access to high-quality medical services and contributing to public health improvement. Through this partnership, we aim to support the self-sufficiency of Indonesia’s medical device industry. CGBIO is committed to being more than just a supplier—we strive to be a key partner in the growth of Indonesia’s medical device manufacturing sector. By working closely with local medical professionals on research and development, expanding education programs, and facilitating technology transfer, we will help Indonesia solidify its position as a medical device hub in Asia.”
Eric Aoh, Head of Indonesia Business at CGBIO, added, “CGBIO is not only focused on manufacturing medical products in Indonesia but also on enhancing the surgical skills of local doctors. To achieve this, we are continuously organizing doctors training sessions, including KOL conferences.”
Budi Gunadi Sadikin, Indonesia’s Minister of Health, commented, “The COVID-19 pandemic has highlighted the importance of local medical device production and technological self-sufficiency. The domestic production of critical medical devices, such as cardiovascular stents, bone graft materials, and wound care products, is essential for public health. In this regard, CGBIO’s plans to expand local manufacturing, strengthen research collaboration, and train medical professionals will make a meaningful contribution to the growth of Indonesia’s medical device industry.”
